Overview

Using Silica 12CH to Mitigate the Effects and Symptoms of Silicosis in Brazil

Status:
NOT_YET_RECRUITING
Trial end date:
2026-03-01
Target enrollment:
Participant gender:
Summary
This clinical study aims to address a research and clinical treatment gap related to individuals with symptoms of Silicosis resulting from quartzite mining work. Silicosis represents a challenge in this specific population in Sao Thome das Letras, Minas Gerais. Silicosis is a severe disease and is considered incurable. Current conventional medicine only offers palliative care for those with Silicosis, highlighting the important and urgent need for research into complementary care approaches.
Phase:
EARLY_PHASE1
Details
Lead Sponsor:
HOHM Foundation
Treatments:
gp100 Melanoma Antigen